Macareal, Jenefe B.

HRN: 23-43-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
AMPICILLIN 1GM (VIAL)
08/24/2023
08/31/2023
IVTT
140mg
Q12
Neonatal Pneumonia
Checking Final Appropriateness 
08/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/24/2023
08/31/2023
IVTT
34mg
Q24
Neonatal Pneumonia
Checking Final Appropriateness 
08/26/2023
CEFTRIAXONE 1G (VIAL)
08/26/2023
09/01/2023
IVT
110mg
Q12
PCAP, T/C Aspiration Pneumonia
Checking Final Appropriateness 
08/26/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/26/2023
09/01/2023
IVT
200mg
Q6
Pcap
Checking Final Appropriateness 
08/27/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
08/27/2023
09/03/2023
ORAL
0.8ml
Bid
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: